Research Article
Circulating Immune Landscape Profiling in Psoriasis Vulgaris and Psoriatic Arthritis by Mass Cytometry
Table 1
Demographics and clinical features of the active PsA group and active PsV group.
| | Clinical feature | Active PsA (n = 7) | Active PsV (n = 7) | p-Value |
| | Demographics | | Age, mean ± SD (years) | 43.9 ± 11.7 | 36.7 ± 11.0 | 0.264a | | Gender, male (%) | 4 (57.14) | 5 (71.43) | 0.999b | | Clinical assessments | | PASI | | Mean ± SD | 7.94 ± 4.20 | 7.90 ± 4.16 | 0.985a | | Mild (<3) | 2 | 2 | — | | Moderate (3–10) | 2 | 2 | — | | Severe (<10) | 3 | 3 | — | | TJC (0–66) | 2 (1–10) | / | / | | SJC (0–66) | 2 (1–7) | / | / | | Pain VAS (0–10) | 4 (2–5) | / | / |
|
|
Abbreviations: PASI, psoriasis area and severity Index; TJC, tender joint count; SJC, swollen joint count; and VAS, visual analogue scale. a: t-test. b: Fisher’s exact test.
|
